These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1478168)

  • 41. Adjuvant therapy of node-negative breast cancer.
    Hall PD; Lesher BA; Hall RK
    Ann Pharmacother; 1995 Mar; 29(3):289-98. PubMed ID: 7606076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group.
    Baum M; Houghton J; Riley D
    Acta Oncol; 1992; 31(2):251-7. PubMed ID: 1622642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tamoxifen in axillary node--negative breast cancer: multisystem benefits and risks.
    Love RR
    Cancer Invest; 1992; 10(6):587-93. PubMed ID: 1422894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.
    Mouridsen HT; Rose C; Overgaard M; Dombernowsky P; Panduro J; Thorpe S; Rasmussen BB; Blichert-Toft M; Andersen KW
    Acta Oncol; 1988; 27(6A):699-705. PubMed ID: 3064775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy.
    Talvensaari-Mattila A; Pääkko P; Blanco-Sequeiros G; Turpeenniemi-Hujanen T
    Breast Cancer Res Treat; 2001 Jan; 65(1):55-61. PubMed ID: 11245340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial.
    Rydén S; Fernö M; Möller T; Aspegren K; Bergljung L; Killander D; Landberg T
    Acta Oncol; 1992; 31(2):271-4. PubMed ID: 1622645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.
    Robertson JF; Todd JH; Ellis IO; Elston CW; Blamey RW
    BMJ; 1988 Aug 20-27; 297(6647):511-4. PubMed ID: 3139179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.
    Castiglione M; Gelber RD; Goldhirsch A
    J Clin Oncol; 1990 Mar; 8(3):519-26. PubMed ID: 2407812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The modified radical mastectomy of Patey: technique and experience.
    Staunton MD; Melville DM; Monterrosa A; Thomas J
    Ann Acad Med Singap; 1993 Mar; 22(2):233-6. PubMed ID: 8363339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse.
    de Takats PG; Dunn JA; Kerr DJ; Morrison JM
    Cancer Treat Rev; 1993 Apr; 19 Suppl B():11-9. PubMed ID: 8481929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.
    Ribeiro G; Palmer MK
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):827-30. PubMed ID: 6403101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer.
    Petit T; Borel C; Theobald S; Serin D; Rodier JF; Prevot G; Brettes JP; Klein T
    Ann Surg Oncol; 2003 May; 10(4):369-75. PubMed ID: 12734084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.
    Boyages J; Tiver KW
    Aust N Z J Surg; 1992 May; 62(5):354-63. PubMed ID: 1575655
    [No Abstract]   [Full Text] [Related]  

  • 54. Age-related variation in the treatment and outcomes of patients with breast carcinoma.
    Golledge J; Wiggins JE; Callam MJ
    Cancer; 2000 Jan; 88(2):369-74. PubMed ID: 10640970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant systemic therapy for early breast cancer.
    Lancet; 1992 Jan; 339(8784):27. PubMed ID: 1345955
    [No Abstract]   [Full Text] [Related]  

  • 56. Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodes.
    Scholten C; Sevelda P; Kurz C; Salzer H; Kubista E; Staffen A; Czerwenka K; Spona J; Aiginger P; Zielinski CC
    Eur J Cancer; 1992; 28A(12):2083. PubMed ID: 1419306
    [No Abstract]   [Full Text] [Related]  

  • 57. Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study.
    Martelli G; Moglia D; Boracchi P; Del Prato I; Galante E; De Palo G
    Eur J Cancer; 1993; 29A(15):2080-2. PubMed ID: 8297643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cancer of the breast in men. 106 cases].
    Cutuli BF; Velten M; Forentz P; Hedelin G; Horiot JC; Pavy JJ; N'Guyen TD; Facchini T; Lesaunier F; Prevot G
    Presse Med; 1993 Mar; 22(10):463-6. PubMed ID: 8511067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.
    Al-Mubarak M; Tibau A; Templeton AJ; Cescon DW; Ocana A; Seruga B; Amir E
    PLoS One; 2014; 9(2):e88238. PubMed ID: 24586311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast conservation therapy for invasive breast cancer in Hong Kong: factors affecting recurrence and survival in Chinese women.
    Chow LW; Au GK; Poon RT
    Aust N Z J Surg; 1997; 67(2-3):94-7. PubMed ID: 9068548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.